SCHEMBL7694147

SCHEMBL7694147

O=C(NCC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1Oc1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE P12821 5/20 0.46
L3MBTL1 Q9Y468 4/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
GAA P10253 1/20 0.46
HTT P42858 1/20 0.46
ATM Q13315 1/20 0.46
CTSL P07711 3/20 0.45
LMNA P02545 1/20 0.45
CTSS P25774 1/20 0.45
CTSK P43235 1/20 0.45
GPR132 Q9UNW8 1/20 0.44
KDM4E B2RXH2 1/20 0.44
ACE2 Q9BYF1 2/20 0.44
MAPK8 P45983 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43
MEN1 O00255 1/20 0.43
RECQL P46063 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7694696 0.89 KDM4E (0.47) L3MBTL1ALDH1A1HPGDGAAHTT
SCHEMBL7666903 0.85 KDM4E (0.47) L3MBTL1ALDH1A1HPGDGAAHTT
SCHEMBL7701622 0.83 L3MBTL1 (0.44) L3MBTL1ALDH1A1HPGDGAAHTT
SCHEMBL7701336 0.82 CASP1 (0.49) L3MBTL1ALDH1A1HPGDGAAHTT
SCHEMBL7689953 0.81 CHRNB2 (0.52) ACEL3MBTL1HTTCTSLCTSS
SCHEMBL7382832 0.77 ROCK2 (0.51) L3MBTL1ALDH1A1HPGDGAAHTT
SCHEMBL7787791 0.77 ROCK2 (0.51) L3MBTL1ALDH1A1HPGDGAAHTT
SCHEMBL7690558 0.77 CAPN1 (0.60) ACECTSLCTSSCTSKACE2
SCHEMBL7693478 0.76 ACE (0.45) ACECTSLCTSSCTSK
SCHEMBL7659831 0.75 KDM4E (0.48) L3MBTL1ALDH1A1HPGDGAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed